Patents Examined by Joshua Andrew Schum-Houck
-
Patent number: 11779254Abstract: A wearable electronic device is provided. The electronic device includes a plurality of electrodes configured to measure a biometric signal, an offset correction circuit, at least one processor operatively connected with the plurality of electrodes and the offset correction circuit, and a memory operatively connected with the at least one processor, wherein the memory stores instructions executed to enable the at least one processor to measure an offset between voltages via at least two electrodes among the plurality of electrodes and correct the offset via the offset correction circuit to allow the measured offset to fall within a threshold range.Type: GrantFiled: November 17, 2020Date of Patent: October 10, 2023Assignee: Samsung Electronics Co., Ltd.Inventors: Hyunjun Jung, Gunwoo Jin
-
Patent number: 11738204Abstract: In some examples, a coil electrode assembly includes a coil electrode including a plurality of windings and extending from an electrode proximal end to an electrode distal end, the coil electrode defining an electrode lumen from the electrode proximal end to the electrode distal end. The coil electrode assembly further includes an insulative tube extending within the lumen of the coil electrode such that the coil electrode extends along an outer surface of the insulative tube. The coil electrode is partially embedded within the insulative tube when the insulative tube is in an expanded state to maintain a spacing between the windings.Type: GrantFiled: July 28, 2022Date of Patent: August 29, 2023Assignee: Medtronic, Inc.Inventors: Douglas Rentas Torres, George W. McFall, William J. Clemens, Dina L. Williams
-
Patent number: 11730420Abstract: Embodiments of the present disclosure describe methods, systems, and computer storage media for detecting sepsis in a maternal patient and causing for display a visual indicator of a graphical object. In some aspects sepsis may be detected based on a maternal patient's patient information and/or clinical diagnostic. Technologies described herein may be used to determine maternal-fetal sepsis and provide a graphical object of a patient's risk of the maternal-fetal sepsis. The visual indicator and graphical object may be identifiable to a clinician as a warning of a risk for maternal-fetal sepsis. In this way, maternal-fetal sepsis may be identified and a graphical object may be generated, facilitating timely treatment and early diagnosis of maternal-fetal sepsis.Type: GrantFiled: December 17, 2019Date of Patent: August 22, 2023Assignee: Cerner Innovation, Inc.Inventors: Prashant Pagi, Nishat Y., Soumen Tapadar, Imran Shaikh
-
Patent number: 11730626Abstract: A method is disclosed for providing control data for an eye surgical laser of a treatment apparatus for the removal of a tissue. The method includes using a control device for determining a wavefront of a cornea and Zernike polynomials from the wavefront and calculating a respective tissue geometry for each Zernike polynomial. A combination of Zernike polynomials describes a tissue removal geometry. The control device ascertains a subgroup of the Zernike polynomials by an optimization calculation, which uses a preset condition to select Zernike polynomials. The condition is preset by a maximized target corneal geometry and a target imaging correction to be achieved. The target corneal geometry is a difference between a corneal geometry and the tissue removal geometry. An optimized tissue removal geometry is found using the subgroup and control data for controlling the eye surgical laser, which uses the optimized tissue removal geometry for separating the tissue.Type: GrantFiled: October 29, 2021Date of Patent: August 22, 2023Assignee: SCHWIND eye-tech-solutions GmbHInventor: Samuel Arba Mosquera
-
Patent number: 11717698Abstract: A therapy, treatment and process for inactivating and/or killing COVID-19 (Corona Virus Disease 2019) is provided, including a low-dose, full body, Ultraviolet A1 (UV-A1, 360-400 nm) photon therapy, wherein the UV-A1 photon therapy activates singlet oxygen (1O2), which inactivates and/or kills COVID-19. UV-A1 therapy of the present invention can also be used to help alleviate symptoms and secondary illnesses caused by COVID-19. UV-A1 therapy of the present invention can also be used to help alleviate and treat pre-existing conditions of people that are also suffering from COVID-19 and worsened by COVID-19.Type: GrantFiled: April 23, 2021Date of Patent: August 8, 2023Inventor: Hugh McGrath, Jr.
-
Patent number: 11678839Abstract: A device includes an angiography module, a phototherapy module, a carrier including an optical filter and accommodating the angiography module and the phototherapy module, and a control unit controlling operation of the angiography module and the phototherapy module. The angiography module includes infrared LEDs emitting infrared light through the optical filter to irradiate a limb of a subject, and an infrared sensor sensing a part of the infrared light reflected off the limb to generate a result, based on which the control unit generates an angiogram. The phototherapy module emits infrared light through the optical filter to irradiate the limb for phototherapy.Type: GrantFiled: April 15, 2021Date of Patent: June 20, 2023Assignee: Taipei Medical UniversityInventor: Jian-Chiun Liou
-
Patent number: 11660163Abstract: A surgical instrument is disclosed including an end effector operable to treat tissue, a shaft extending proximally from the end effector, and a housing assembly extending proximally from the shaft. The housing assembly includes a radio-frequency identification (RFID) scanner and a motor-assembly compartment including a motor assembly interchangeably retained by the motor-assembly compartment in an assembled configuration. The motor assembly is movable relative to the motor-assembly compartment between the assembled configuration and an unassembled configuration. The motor assembly includes a motor configured to drive the end effector to treat the tissue and an RFID tag detectable by the RFID scanner in the assembled configuration. The RFID tag stores motor-assembly information.Type: GrantFiled: June 30, 2019Date of Patent: May 30, 2023Assignee: Cilag GmbH InternationalInventors: Frederick E. Shelton, IV, Kevin M. Fiebig
-
Patent number: 11660462Abstract: An implant system for photodynamic therapy with a light source for radiating light which is implantable in a resection cavity, and with an autonomous control unit which is connectable via a supply line to the light source.Type: GrantFiled: March 11, 2020Date of Patent: May 30, 2023Inventors: Felix Capanni, Marc-Eric Halatsch
-
Patent number: 11654295Abstract: This invention relates to a therapeutic device for treating a human or animal body, comprising an array of infrared-emitting elements disposed on or within a flexible substrate and attached to the body part to be treated using an attachment means, said array comprising a first plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 3-7 micrometer wavelength spectrum and having a peak wavelength between 3 and 7 micrometers, and a second plurality of infrared-emitting ceramic elements having a specific spectral luminance covering at least a part of the 7-14 micrometer wavelength spectrum and having a peak wavelength between 7 and 14, that provides an effective means to healing the body.Type: GrantFiled: January 24, 2020Date of Patent: May 23, 2023Assignee: Aldi Far-IR Products, Inc.Inventor: Albert Chin-Tang Wey
-
Patent number: 11648057Abstract: A catheter system for treating a treatment site within or adjacent to a vessel wall or a heart valve, includes a light source, a balloon, a light guide and an optical analyzer assembly. The light source generates first light energy. The balloon is positionable substantially adjacent to the treatment site. The balloon has a balloon wall that defines a balloon interior that receives a balloon fluid. The light guide receives the first light energy and guides the first light energy in a first direction from a guide proximal end toward a guide distal end positioned within the balloon interior. The optical analyzer assembly optically analyzes a second light energy from the light guide that moves in a second direction that is opposite the first direction. The optical analyzer assembly includes a safety shutdown system to inhibit the first light energy from being received by the guide proximal end of the light guide.Type: GrantFiled: May 4, 2022Date of Patent: May 16, 2023Assignee: Bolt Medical, Inc.Inventors: Christopher A. Cook, Eric Schultheis, Rachel Lynn Troutman, James Dee Swift
-
Patent number: 11633620Abstract: A method for optogenetics experiments, based on wavefront shaping and including: calculating the transmission matrix between an input end and an output end of the multimode fiber under a fixed shape; implanting the output end into an intracranial space of an experimental subject; and performing wavefront compensation to a light to be input into the input end, according to the spatial position of the optical stimulation and the transmission matrix of the multimode fiber, to form a compensated expanded light, and inputting the compensated expanded light from the input end into the multimode fiber, such that the compensated expanded light, after being transmitted by the multimode fiber to the output end and output from the output end, is capable of focusing at the spatial position of the optical stimulation.Type: GrantFiled: April 8, 2020Date of Patent: April 25, 2023Assignee: THE HONG KONG POLYTECHNIC UNIVERSITY SHENZHEN RESEARCH INSTITUTEInventors: Puxiang Lai, Lei Sun, Tianting Zhong, Zhihai Qiu
-
Patent number: 11622779Abstract: A photoacoustic catheter can include an elongate shaft and a first photoacoustic transducer. The elongate shaft can extend from a proximal region to a distal region and can include a first light guide that is in optical communication with a light source. The first photoacoustic transducer can be disposed within the distal region of the elongate shaft and can be in optical communication with the first light guide. The first photoacoustic transducer can impart acoustic pressure waves upon a calcified lesion to induce fractures. The first photoacoustic transducer can include a light-absorbing material and a thermal expansion material that can be in contact with one another.Type: GrantFiled: October 16, 2019Date of Patent: April 11, 2023Assignee: Boston Scientific Scimed, Inc.Inventors: Roger W. McGowan, Binh C. Tran, Christopher Smuk, Daniel Frank Massimini
-
Patent number: 11596804Abstract: An illumination apparatus is disclosed, comprising: a first light source having a first spectral light distribution with a first light intensity peak about a first peak wavelength, and a second light source having a second spectral light distribution with a second light intensity peak about a second peak wavelength being different from the first peak wavelength, a third light source having a third spectral light distribution with a main light intensity peak about a third peak wavelength being different from the first peak wavelength and from the second peak wavelength, wherein the illumination apparatus is configured to provide adjustment of light intensity of the first light source and of light of the second light source, wherein the illumination apparatus provides an adjustment of light intensity of the third light source to compensate for the adjusting of the relative light intensity between the first light source and the second light source.Type: GrantFiled: August 27, 2018Date of Patent: March 7, 2023Assignee: BRAINLIT ABInventors: Truls Olof Johan Löwgren, Peter K Andersson, Tord Wingren
-
Patent number: 11589668Abstract: A beauty instrument with mask includes a flexible mask and a controller. The flexible mask includes a first flexible layer, a second flexible layer, a plurality of functional layers located between the first flexible layer and the second flexible layer, and a plurality of electrodes electrically connected with the plurality of functional layers. The functional layer includes a graphene layer. The flexible mask is electrically coupled with the controller via the plurality of electrodes.Type: GrantFiled: January 10, 2020Date of Patent: February 28, 2023Assignee: Beijing FUNATE Innovation Technology Co., LTD.Inventors: Li Fan, Li Qian, Yu-Quan Wang
-
Patent number: 11583339Abstract: A catheter system for treating a treatment site within or adjacent to a vessel wall within a body of a patient includes an energy source, a balloon, and an energy guide. The energy source generates energy. The balloon includes a balloon wall that defines a balloon interior. The balloon is configured to retain a balloon fluid within the balloon interior. The balloon is selectively inflatable with the balloon fluid to expand to an inflated state, wherein when the balloon is in the inflated state the balloon wall is configured to be positioned substantially adjacent to the treatment site. The balloon further includes a balloon central axis that extends through a geometric center of the balloon when the balloon is in the inflated state. The energy guide selectively receives energy from the energy source and guides the energy from the energy source into the balloon interior. The energy guide including a guide distal end that is positioned on the balloon central axis when the balloon is in the inflated state.Type: GrantFiled: October 5, 2020Date of Patent: February 21, 2023Assignee: Bolt Medical, Inc.Inventor: Eric Schultheis
-
Patent number: 11576724Abstract: A catheter for debulking of an undesired deposit from an inner surface of at least one of a blood vessel wall and a stent located in a blood vessel, the catheter having a tip section comprising: circumferentially-directed laser optics; and a circular-action cutter, wherein said circumferentially-directed laser optics is configured to transmit laser radiation for modifying an area of the undesired deposit thereby preparing said area for penetration of said cutter, wherein said cutter is configured to cut through said modified area and thereby debulk at least a part of the undesired deposit. In addition, a catheter for pacemaker and ICD (Implantable Cardioverter Defibrillator) lead extraction is disclosed.Type: GrantFiled: June 10, 2019Date of Patent: February 14, 2023Assignee: Eximo Medical Ltd.Inventors: Ilan Ben-Oren, Yifat Ben-Oren Tamir
-
Patent number: 11565131Abstract: An optical stimulation system includes a light source; an optical lead coupled, or coupleable, to the light source; at least one of a calibration table or a calibration formula, generated by a calibration procedure specifically using the light source and the optical lead of the optical stimulation system; and a control unit coupled, or coupleable, to the light source. The control module includes a memory to store the at least one of the calibration table or the calibration formula, and a processor coupled to the memory and configured for receiving a target light output level, using the at least one of the calibration table or the calibration formula to determine at least one operational parameter for generating the target light output level, and directing the light source, using the at least one operational parameter, to generate light at the target light output level.Type: GrantFiled: March 19, 2019Date of Patent: January 31, 2023Assignees: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (“CEA”)Inventors: Dennis Allen Vansickle, Adam Thomas Featherstone, Claude Chabrol, Michael A. Moffitt, Sarah Renault, Adrien Poizat
-
Patent number: 11565124Abstract: A neural sensing system includes an interrogator that includes an optical head. The optical head is configured to transmit a light signal. The neural sensing system also includes a microprobe configured to contact tissue. The microprobe includes a transducer configured to receive the light signal and modulate the light signal with neural signal information sensed from the tissue. The microprobe also includes a retroreflector configured to reflect the modulated light signal back to the optical head of the interrogator.Type: GrantFiled: August 15, 2018Date of Patent: January 31, 2023Assignee: Northwestern UniversityInventor: Hooman Mohseni
-
Patent number: 11529097Abstract: A subject's Default Mode Network is accessed through corresponding measurements of the Micro-Coherence Oximetry Network Strength (MCO-S). An associated MCO-S system (100) includes a wearable (102), a user device (112) and a processing platform (123). The wearable (102) collects subject information sufficient to enable monitoring and optimization of the subject's Default Mode Network include sensors such as pulse oximetry instrumentation and EEG electrodes to obtain brainwave data, oxygen saturation data, heart rate variability data, and galvanic skin conductance data. Information from the sensors may be communicated to a user device (112), such as a cell phone or VR headset. The user device (112) communicates with a remote processing platform (123) that may execute artificial intelligence functionality and other logic in connection with assessing the patient's micro-coherence network strength and optimizing behavior modification protocols in relation to attributes and objectives of the subject.Type: GrantFiled: November 25, 2019Date of Patent: December 20, 2022Assignee: Wellness IP, Inc.Inventor: Michael Peter Hickey
-
Patent number: 11529512Abstract: A method for using beauty instrument with mask is provided. The method comprises providing a beauty instrument with mask comprising a flexible mask and a controller, applying the flexible mask of on a user's face, and turning on the controller and selecting a function button on the controller, inputting a current to a plurality of functional layers in the flexible mask, and stimulating face skin with the current.Type: GrantFiled: January 10, 2020Date of Patent: December 20, 2022Assignee: Beijing FUNATE Innovation Technology Co., LTD.Inventors: Li Fan, Li Qian, Yu-Quan Wang